FDA drug candidacy acceptance criteria and steps: problems and way forward

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorEzzat, Shahira M
dc.contributor.authorHelmy, Mahitab
dc.contributor.authorWalag, Angelo Mark P
dc.contributor.authorMtewa, Andrew
dc.date.accessioned2020-01-23T15:13:27Z
dc.date.available2020-01-23T15:13:27Z
dc.date.issued2019-08
dc.identifier.doihttps://doi.org/
dc.identifier.otherhttps://doi.org/
dc.identifier.urihttps://t.ly/dgr3M
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.ispartofseries  In book: Phytochemicals as Lead Compounds for New Drug Discovery, Publisher: Elsevier,;pp.39-63
dc.subjectuniversity ofen_US
dc.titleFDA drug candidacy acceptance criteria and steps: problems and way forwarden_US
dc.typeBook chapteren_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
51 B
Format:
Item-specific license agreed upon to submission
Description: